Literature DB >> 19893026

Signal regulatory protein-beta1: a microglial modulator of phagocytosis in Alzheimer's disease.

Sadanand Gaikwad1, Sergey Larionov, Yiner Wang, Holger Dannenberg, Takashi Matozaki, Alon Monsonego, Dietmar R Thal, Harald Neumann.   

Abstract

The signal regulatory protein-beta1 (SIRPbeta1) is a DAP12-associated transmembrane receptor expressed in a subset of hematopoietic cells. Recently, it was shown that peritoneal macrophages express SIRPbeta1, which positively regulated phagocytosis. Here, we found that SIRPbeta1 was up-regulated and acted as a phagocytic receptor on microglia in amyloid precursor protein J20 (APP/J20) transgenic mice and in Alzheimer's disease (AD) patients. Interferon (IFN)-gamma and IFN-beta stimulated gene transcription of SIRPbeta1 in cultured microglia. Activation of SIRPbeta1 on cultured microglia by cross-linking antibodies induced reorganization of the cytoskeleton protein beta-actin and suppressed lipopolysaccharide-induced gene transcription of tumor necrosis factor-alpha and nitric oxide synthase-2. Furthermore, activation of SIRPbeta1 increased phagocytosis of microsphere beads, neural debris, and fibrillary amyloid-beta (Abeta). Phagocytosis of neural cell debris and Abeta was impaired after lentiviral knockdown of SIRPbeta1 in primary microglial cells. Thus, SIRPbeta1 is a novel IFN-induced microglial receptor that supports clearance of neural debris and Abeta aggregates by stimulating phagocytosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19893026      PMCID: PMC2789620          DOI: 10.2353/ajpath.2009.090147

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  47 in total

Review 1.  TREMs in the immune system and beyond.

Authors:  Marco Colonna
Journal:  Nat Rev Immunol       Date:  2003-06       Impact factor: 53.106

2.  Amyloid-beta immunization effectively reduces amyloid deposition in FcRgamma-/- knock-out mice.

Authors:  Pritam Das; Victor Howard; Nicole Loosbrock; Dennis Dickson; M Paul Murphy; Todd E Golde
Journal:  J Neurosci       Date:  2003-09-17       Impact factor: 6.167

Review 3.  Microglia and neuroprotection: implications for Alzheimer's disease.

Authors:  Wolfgang J Streit
Journal:  Brain Res Brain Res Rev       Date:  2005-01-15

Review 4.  Microglial cells in neurodegenerative disorders.

Authors:  Marcin Wojtera; Beata Sikorska; Tomasz Sobow; Paweł P Liberski
Journal:  Folia Neuropathol       Date:  2005       Impact factor: 2.038

Review 5.  Glia and their cytokines in progression of neurodegeneration.

Authors:  Robert E Mrak; W Sue T Griffin
Journal:  Neurobiol Aging       Date:  2005-03       Impact factor: 4.673

6.  LPS receptor (CD14): a receptor for phagocytosis of Alzheimer's amyloid peptide.

Authors:  Yang Liu; Silke Walter; Massimiliano Stagi; Dmitry Cherny; Maryse Letiembre; Walter Schulz-Schaeffer; Holger Heine; Botond Penke; Harald Neumann; Klaus Fassbender
Journal:  Brain       Date:  2005-04-27       Impact factor: 13.501

7.  Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice.

Authors:  Tony Wyss-Coray; Fengrong Yan; Amy Hsiu-Ti Lin; John D Lambris; Jessy J Alexander; Richard J Quigg; Eliezer Masliah
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-15       Impact factor: 11.205

Review 8.  Collections and ficolins: humoral lectins of the innate immune defense.

Authors:  Uffe Holmskov; Steffen Thiel; Jens C Jensenius
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

Review 9.  Microglia as liaisons between the immune and central nervous systems: functional implications for multiple sclerosis.

Authors:  Monica J Carson
Journal:  Glia       Date:  2002-11       Impact factor: 8.073

10.  Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2.

Authors:  Kazuya Takahashi; Christian D P Rochford; Harald Neumann
Journal:  J Exp Med       Date:  2005-02-21       Impact factor: 14.307

View more
  33 in total

1.  Ablation of TNF-RI/RII expression in Alzheimer's disease mice leads to an unexpected enhancement of pathology: implications for chronic pan-TNF-α suppressive therapeutic strategies in the brain.

Authors:  Sara L Montgomery; Michael A Mastrangelo; Diala Habib; Wade C Narrow; Sara A Knowlden; Terry W Wright; William J Bowers
Journal:  Am J Pathol       Date:  2011-08-09       Impact factor: 4.307

Review 2.  Tumor necrosis factor-alpha and the roles it plays in homeostatic and degenerative processes within the central nervous system.

Authors:  Sara L Montgomery; William J Bowers
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-05       Impact factor: 4.147

Review 3.  It's a cell-eat-cell world: autophagy and phagocytosis.

Authors:  Elizabeth A Oczypok; Tim D Oury; Charleen T Chu
Journal:  Am J Pathol       Date:  2013-01-29       Impact factor: 4.307

4.  Amyloid-β42 protofibrils are internalized by microglia more extensively than monomers.

Authors:  Lisa K Gouwens; Nyasha J Makoni; Victoria A Rogers; Michael R Nichols
Journal:  Brain Res       Date:  2016-08-13       Impact factor: 3.252

Review 5.  The Neuro-Immune-Regulators (NIREGs) Promote Tissue Resilience; a Vital Component of the Host's Defense Strategy against Neuroinflammation.

Authors:  Yosra Bedoui; Jim W Neal; Philippe Gasque
Journal:  J Neuroimmune Pharmacol       Date:  2018-06-16       Impact factor: 4.147

Review 6.  CD4 T cells in immunity and immunotherapy of Alzheimer's disease.

Authors:  Alon Monsonego; Anna Nemirovsky; Idan Harpaz
Journal:  Immunology       Date:  2013-08       Impact factor: 7.397

7.  Microglial immunoreceptor tyrosine-based activation and inhibition motif signaling in neuroinflammation.

Authors:  Bettina Linnartz; Yiner Wang; Harald Neumann
Journal:  Int J Alzheimers Dis       Date:  2010-06-22

8.  Dual induction of TREM2 and tolerance-related transcript, Tmem176b, in amyloid transgenic mice: implications for vaccine-based therapies for Alzheimer's disease.

Authors:  Benoit Melchior; Angie E Garcia; Bor-Kai Hsiung; Katherine M Lo; Jonathan M Doose; J Cameron Thrash; Anna K Stalder; Matthias Staufenbiel; Harald Neumann; Monica J Carson
Journal:  ASN Neuro       Date:  2010-07-12       Impact factor: 4.146

9.  T cells specifically targeted to amyloid plaques enhance plaque clearance in a mouse model of Alzheimer's disease.

Authors:  Yair Fisher; Anna Nemirovsky; Rona Baron; Alon Monsonego
Journal:  PLoS One       Date:  2010-05-26       Impact factor: 3.240

Review 10.  TYROBP in Alzheimer's disease.

Authors:  Jing Ma; Teng Jiang; Lan Tan; Jin-Tai Yu
Journal:  Mol Neurobiol       Date:  2014-07-23       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.